112 related articles for article (PubMed ID: 7911603)
1. Molecular biology of head and neck cancer.
Brachman DG
Semin Oncol; 1994 Jun; 21(3):320-9. PubMed ID: 7911603
[No Abstract] [Full Text] [Related]
2. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
4. [Oncogenes and their significance for head and neck cancers].
Issing WJ; Wustrow TP; Heppt W
HNO; 1992 Aug; 40(8):283-91. PubMed ID: 1517116
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes and antioncogenes in human breast carcinoma.
Leslie KO; Howard P
Pathol Annu; 1992; 27 Pt 1():321-42. PubMed ID: 1346552
[No Abstract] [Full Text] [Related]
6. Oncogenes in head and neck cancer.
Irish JC; Bernstein A
Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
8. p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene.
Weinberg WC; Azzoli CG; Kadiwar N; Yuspa SH
Cancer Res; 1994 Nov; 54(21):5584-92. PubMed ID: 7923201
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of head and neck squamous cell carcinoma.
Hardisson D
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):502-8. PubMed ID: 12736744
[TBL] [Abstract][Full Text] [Related]
10. Oncogenes and uterine function.
Stancel GM; Baker VV; Hyder SM; Kirkland JL; Loose-Mitchell DS
Oxf Rev Reprod Biol; 1993; 15():1-42. PubMed ID: 8336974
[No Abstract] [Full Text] [Related]
11. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.
Field JK
Eur J Cancer B Oral Oncol; 1992 Jul; 28B(1):67-76. PubMed ID: 1330149
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG
Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388
[TBL] [Abstract][Full Text] [Related]
13. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
[TBL] [Abstract][Full Text] [Related]
14. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
15. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
17. [Alterations of oncogenes in human cancers].
Tsuda H; Hirohashi S
Gan To Kagaku Ryoho; 1993 May; 20(7):977-83. PubMed ID: 8098201
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
